Table 1.
Binding Partners of SHP-2 in Gastrointestinal Cells
Organs | Proteins | Interactions | Cell types | Cell outcomes | References |
---|---|---|---|---|---|
Stomach | CagA | SH2 domain of SHP-2 and phosphorylated tyrosine in the EPIYA motif of CagA | AGS cells Human gastric epithelial cells |
Increased phosphatase activity of SHP-2 ↓ Induction of the hummingbird phenotype |
47, 59, 62, 117, 118 |
FAK | SHP-2 in complex with CagA and FAK | AGS cells | Dephosphorylation of FAK on Y397, Y576, and Y577 by SHP-2 ↓ Induction of the hummingbird phenotype |
119 | |
gp130 | SHP-2 in complex with gp130 | AGS cells | Activation of ERK1/2 by gp130 Inhibition of the Jak2/STAT3 pathway by SHP-2 |
59 | |
Parafibromin | SH2 domain of SHP-2 and parafibromin | AGS cells | Dephosphorylation of parafibromin on Y290, Y293, and Y315 by SHP-2 ↓ Interaction between dephosphorylated parafibromin and β-catenin ↓ Nuclear accumulation of β-catenin and transcription of Wnt/β-catenin target genes |
30 | |
YAP and TAZ | C-terminal tail of SHP-2 and WW domain and C-terminus PDZ-binding motif of TAZ | AGS cells | Dephosphorylation of YAP/TAZ by SHP-2 ↓ Nuclear accumulation of SHP-2 ↓ Interaction between dephosphorylated parafibromin ↓ Transcription of TEAD-regulated genes |
31 | |
Intestine | IL22R1 | SHP-2 and phosphorylated IL22R1 (Y251, Y301) | SW480 cells | Activation of the ERK1/2 and Jak/STAT3 signaling pathways by IL22 | 120 |
Bgp1 | N-SH2 domain of SHP-2 and phosphorylated Y in the ITIM motif of Bgp1 | CT51 cells | ND | 121 | |
Liver | FRS2α | SH2 domain of SHP-2 and phosphorylated Y of FRS2α | Hep3B cells Mouse hepatic cells |
Activation of the ERK1/2 pathway by FGFR4 | 105 |
Gab1 | SH2 domain of SHP-2 and phosphorylated Y of Gab1 | Hep3B cells Hep2G cells Mouse hepatic cells |
Activation of the ERK1/2 pathway | 90, 105, 122 | |
Liver and pancreas | COP1 FASN |
N-SH2 domain of SHP-2 in a complex, association with FASN and COP1 | Mouse hepatic cells Mouse pancreatic cells |
FASN ubiquitination and degradation ↓ Impact on lipid metabolism and glucose homeostasis |
101 |
Pancreas | p85/PI3K IRS2 |
SHP-2 in a complex with p85 and IRS2 | INS-1 832/13 pancreatic cells |
Glucose-induced activation of the Akt/FoxO1 pathway ↓ Insulin production |
98 |
Sprouty 1 | ND | INS-1 832/13 cells |
Dephosphorylation of Sprouty 1 on Y by SHP-2 ↓ Glucose-induced activation of the ERK1/2 pathway ↓ Insulin production |
98 |
AGS, human gastric carcinoma cells; Bgp1, biliary glycoprotein 1; COP1, constitutive photomorphogenesis protein 1; CT51, mouse colonic carcinoma cells; EPIYA, Glu-Pro-Ile-Tyr-Ala; FAK, focal adhesion kinase; FASN, fatty acid synthase; FRS2α, fibroblast growth factor receptor substrate 2 α; Gab1, Grb2-associated binding protein; Hep, human hepatocellular carcinoma cells; IL22R1, interleukin-22 receptor 1; INS-1 832/13 cells, insulin-producing β-cells; IRS2, insulin receptor substrate 2; ITIM, immunoreceptor tyrosine-based inhibitor motif; ND, not determined; SW480, human colonic adenocarcinoma cells; TAZ, transcriptional coactivator with PDZ-binding motif; Y, tyrosine; gp130, glycoprotein 130; YAP, yes-associated protein.